Navigation Links
Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
Date:5/18/2008

Study Suggests that Adding Singulair to Advair Offers no Additional

Improvement in Overall Asthma Control

RESEARCH TRIANGLE PARK, N.C. and TORONTO, May 18 /PRNewswire-FirstCall/ -- Patients with both asthma and allergic rhinitis, or seasonal allergies, experience significantly better lung function when treated with Advair Diskus(R) (fluticasone propionate and salmeterol inhalation powder) as compared with Singulair (montelukast sodium). The results of the 660-subject study were presented today at the International Conference of the American Thoracic Society meeting in Toronto.

The study also showed patients treated with Advair plus Singulair saw no measurable improvement compared to patients treated with Advair alone in their asthma symptoms or albuterol use. In another comparison patients using Advair plus the intranasal corticosteroid, fluticasone propionate nasal spray, saw significant improvement in daytime nasal symptoms compared to patients treated with Advair plus Singulair (p<0.001).

"These findings give us a greater understanding of how to treat patients with asthma and seasonal allergies, two diseases that often are seen in tandem," said Rohit Katial, MD, National Jewish Medical Research Center. "By using the right combination of treatments, physicians can help patients gain relief from the symptoms of both diseases."

The study included people age 15 and up who had both persistent asthma and seasonal allergies. Patients received one of four different treatments: Advair Diskus 100/50 twice daily, Singulair 10 mg once daily, Advair 100/50 twice daily with Singulair 10 mg once daily or Advair 100/50 twice daily with fluticasone propionate nasal spray 200 mcg once daily. Those who received Advair alone had significant improvements in their morning peak expiratory flow, a measure of asthma control, as compared with Singulair alone (p<0.001). Secondary endpoints, including symptom-free days and rescue-treat
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma
2. Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings
3. Pharmacopeias First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
4. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer
7. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
8. New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)
9. AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients
10. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
11. Prism Glasses Expand the View for Patients with Hemianopia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009).../ -- Volcano Corporation (Nasdaq: VOLC ), a leade...ducts for the diagnosis and treatment of coronary ...will be participating in the Third Annual Canaccor...0. ,, The presentation by Scott Huennekens, pre...1 p.m., Pacific Standard Time (4 p.m., Eastern Sta...
(Date:11/9/2009)...tCall/ -- Cardiac Science Corporation (Nasdaq:...fibrillator ( AED ) and diagnostic cardiac monit...llion for the third quarter ended September 30, 20...y also recorded a charge of $18.5 million for an A...44.0 million to increase its valuation allowance a...
(Date:11/9/2009)...Call/ -- Boston Scientific Corporation (NYSE: BSX...8th annual Global Congress for Minimally Invasive ...in Orlando, Florida. Results from two clinical st...ology/Gynecology products, including pelvic floor ...ems used to treat pelvic floor vaginal wall prolap...
Breaking Medicine Technology:Volcano Corporation Presentation at Canaccord Adams Conference to Be Webcast 2Cardiac Science Announces Third Quarter Results 2Cardiac Science Announces Third Quarter Results 3Cardiac Science Announces Third Quarter Results 4Cardiac Science Announces Third Quarter Results 5Cardiac Science Announces Third Quarter Results 6Cardiac Science Announces Third Quarter Results 7Cardiac Science Announces Third Quarter Results 8Cardiac Science Announces Third Quarter Results 9Cardiac Science Announces Third Quarter Results 10Cardiac Science Announces Third Quarter Results 11Cardiac Science Announces Third Quarter Results 12Cardiac Science Announces Third Quarter Results 13Cardiac Science Announces Third Quarter Results 14Cardiac Science Announces Third Quarter Results 15Cardiac Science Announces Third Quarter Results 16Cardiac Science Announces Third Quarter Results 17Cardiac Science Announces Third Quarter Results 18Cardiac Science Announces Third Quarter Results 19Cardiac Science Announces Third Quarter Results 20Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 2Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 3Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 4Boston Scientific's Urology/Gynecology Products Featured in Studies at Global Congress 5New research 3A Consumption of sugar substitutes assists in long term weight control 55125 1New research 3A Consumption of sugar substitutes assists in long term weight control 55125 2When cells run out of fuel 9677 1When cells run out of fuel 9677 2Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 1Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 2Bioniche Phase III Clinical Trial with Urocidin 28TM 29 Given Continued Green Light by DMC 55122 3
...07 - Hemispherx Biopharma,Inc. (AMEX: HEB) announ...l of Immunology, April 2007) that explains the uni...rimental therapeutic,Ampligen(R) (Poly I : Poly C...notherapy for Chronic Fatigue Syndrome and as an,a...-reviewed study shows conclusively that the biolog...
...frontera AG announced,that an interim report regar...eratosis was received today from an independent re... investigate the,efficacy and safety of several do...ments received today refer to the clinical results... about the results,after twelve weeks will follow....
Other Medicine Technology:New Report Illuminates Ampligen's Unique Mechanism of Action 2New Report Illuminates Ampligen's Unique Mechanism of Action 3New Report Illuminates Ampligen's Unique Mechanism of Action 4
(Date:11/9/2009)... Businesses of all sizes lookin...for the H1N1 pandemic have a new resource at their... (PRWEB) November 9, 2009 -- Human resource (HR) p...d response efforts for the H1N1 pandemic have a ne...nnesota’s Center for Infectious Disease Rese...
(Date:11/9/2009)... House Delivers on Election Promise. Now Is Time f...wire-USNewswire/ -- The following is a statement b...enerations of struggle and decades of delay, the U...t -- and, to pass historic reform legislation to a... access to high quality, affordable health care. T...
(Date:11/9/2009)...RIVERWOODS, Ill., Nov. 9 The House...ealth Care for America Act , which passed by a vot...tes several significant changes to the tax code an...ely to appear in any Senate version, requiring ext...H has issued a Special Tax Briefing on the tax...
(Date:11/9/2009)...WASHINGTON, Nov. 9 The Churchill...s Award For Leadership to J.W. "Bill" Marriott for...rough progressive free market practices and foster...e. Mr. Marriott will receive his award at a ceremo...ngton D.C. Four Seasons Hotel. ,, "This is a t...
(Date:11/9/2009)...in mice reports success with drugs that inhibit es...ews) -- Two drugs used to treat breast cancer and ...ccording to a new study. , The drugs also clear...and prevented the onset of cancer in mice with pre...vestrant and the breast cancer/osteoporosis drug r...
Breaking Medicine News(10 mins):Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 2Health News:New H1N1 Flu Guide Offers Practical Tools and Tips for HR Professionals 3Health News:Statement of Anna Burger, Chair, Change to Win, on U.S. House Vote for Health Care Reform 2Health News:CCH Briefing Details Tax Provisions of House Health Care Bill 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2
... disease that can have Complication as its other n...could have, the dreaded would be the foot ulcer, a...n. For diabetics with this dreaded foot ulcer, ... healing of foot ulcers. People with diabetes m...
...are being developed on a daily basis. One of these...nt of those suffering from a degenerative eye cond...sels to grow underneath the retina and leak fluid,...of damaging the retinal tissue. This is a two-s...
...l companies hope to strike a pot of gold by making... war that is likely to escalate in coming days. ...panies to develop anti-AIDS drugs and market it in... entry of four more pharmaceutical companies inclu...
...ing the worst forms of nightmare over the past 3 w... but the threat of malaria . Malaria , not a ... tribal areas of Munger, 200 km (125 miles) southe...id the state's health minister Mr.Shakuni Choudhar...
... the recent issue of the American Journal of Epide...elp protect against a hip fracture. According to D...al, Glostrup, Denmark, and colleagues, when people... hip fractures. In the study, they found tha...
...ministration (FDA) at a conference in Washington, ...ts kind that directly removes the sign of a protei...eatment for chronic myelogenous leukemia (CML). ...rectly cause the disease. Gleevec, was discover...
Other Medicine News:
Nova Epi-fluorescence
...are the hallmark of these stereozoom fluorescent m...n mind. The top (incident) circular 9W fluorescent...inating shadows while remaining cool to the touch....e with 10x to 44x zoom magnification or high-power...
...vative and efficient inverted routine microscope. ...cility. Improved mechanics and increased stability...cular and TS100-F trinocular models. The TS100-F t...ts Nikon's FX-III series photomicrographic systems...
...system utilizes an evanescent wave to excite singl...e coverglass. Extendable "stratum structure". This...th TIRF and epi-fluorescence illumination systems,...ies. It also allows their dedicated filters to be ...
Medicine Products: